Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease

Clare P Herd; Claire L Tomlinson; Katherine H O Deane; Marian C Brady; Christina H Smith; Catherine M Sackley; Carl E Clarke

doi:10.1002/14651858.CD002812.pub2

Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease

Clare P Herd
, Claire L Tomlinson
, Katherine H O Deane
, Marian C Brady
, Christina H Smith
, Catherine M Sackley
, Carl E Clarke

Birmingham Clinical Trials Unit

Research output: Contribution to journal › Article › peer-review

33 Citations (Scopus)

Abstract

Parkinson's disease patients commonly suffer from speech and vocal problems including dysarthric speech, reduced loudness and loss of articulation. These symptoms increase in frequency and intensity with progression of the disease). Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids.

Original language	English
Pages (from-to)	CD002812
Journal	Cochrane Database of Systematic Reviews
Volume	8
DOIs	https://doi.org/10.1002/14651858.CD002812.pub2
Publication status	Published - 15 Aug 2012

Bibliographical note

C Smith is listed as C Tomlinson in the article.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Dysarthria
Humans
Language Therapy
Parkinson Disease
Randomized Controlled Trials as Topic
Speech Intelligibility
Speech Therapy
Watchful Waiting

Access to Document

10.1002/14651858.CD002812.pub2

Cite this

@article{95d412f1bcd544a2b91eac631aefe9a5,

title = "Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease",

abstract = "Parkinson's disease patients commonly suffer from speech and vocal problems including dysarthric speech, reduced loudness and loss of articulation. These symptoms increase in frequency and intensity with progression of the disease). Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids.",

keywords = "Dysarthria, Humans, Language Therapy, Parkinson Disease, Randomized Controlled Trials as Topic, Speech Intelligibility, Speech Therapy, Watchful Waiting",

author = "Herd, \{Clare P\} and Tomlinson, \{Claire L\} and Deane, \{Katherine H O\} and Brady, \{Marian C\} and Smith, \{Christina H\} and Sackley, \{Catherine M\} and Clarke, \{Carl E\}",

note = "C Smith is listed as C Tomlinson in the article.",

year = "2012",

month = aug,

day = "15",

doi = "10.1002/14651858.CD002812.pub2",

language = "English",

volume = "8",

pages = "CD002812",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Cochrane Collaboration",

}

TY - JOUR

T1 - Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease

AU - Herd, Clare P

AU - Tomlinson, Claire L

AU - Deane, Katherine H O

AU - Brady, Marian C

AU - Smith, Christina H

AU - Sackley, Catherine M

AU - Clarke, Carl E

N1 - C Smith is listed as C Tomlinson in the article.

PY - 2012/8/15

Y1 - 2012/8/15

N2 - Parkinson's disease patients commonly suffer from speech and vocal problems including dysarthric speech, reduced loudness and loss of articulation. These symptoms increase in frequency and intensity with progression of the disease). Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids.

AB - Parkinson's disease patients commonly suffer from speech and vocal problems including dysarthric speech, reduced loudness and loss of articulation. These symptoms increase in frequency and intensity with progression of the disease). Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids.

KW - Dysarthria

KW - Humans

KW - Language Therapy

KW - Parkinson Disease

KW - Randomized Controlled Trials as Topic

KW - Speech Intelligibility

KW - Speech Therapy

KW - Watchful Waiting

U2 - 10.1002/14651858.CD002812.pub2

DO - 10.1002/14651858.CD002812.pub2

M3 - Article

C2 - 22895930

SN - 1469-493X

VL - 8

SP - CD002812

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

ER -

Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease

Abstract

Bibliographical note

UN SDGs

Keywords

Access to Document

Fingerprint

Cite this